Last update 28 Nov 2025

Influenza vaccine(split virion,BK-01 adjuvant)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Influenza, Human
Originator Organization
Changchun BCHT Biotechnology Co.Changchun BCHT Biotechnology Co.
Active Organization-
Inactive Organization
Changchun BCHT Biotechnology Co.Changchun BCHT Biotechnology Co.
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Influenza vaccine(split virion,BK-01 adjuvant)
NCT05284851
/ Unknown statusPhase 2
A Random, Double-Blind, Multicenter, Positive Control and Placebo Control Phase Two Trail to Evaluate the Safety and Immunogenicity of Live Attenuated Influenza Vaccine in 3-59y Healthy People
CTR20220581
/ Active, not recruitingPhase 2
多中心、随机、双盲、阳性对照和安慰剂对照的三臂设计，评价鼻喷流感减毒活疫苗在3~59周岁健康人群中的免疫原性和安全性的Ⅱ期临床试验
[Translation] A phase II clinical trial with a multicenter, randomized, double-blind, positive-controlled and placebo-controlled three-arm design to evaluate the immunogenicity and safety of nasal spray live attenuated influenza vaccine in healthy people aged 3 to 59 years
CTR20212179
/ Active, not recruitingPhase 1
单中心、随机、双盲、安慰剂对照评价鼻喷流感减毒活疫苗在3~59周岁健康人群中的安全性和免疫原性的Ⅰ期临床试验
[Translation] A single-center, randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of a live attenuated nasal influenza vaccine in healthy people aged 3 to 59 years
100 Clinical Results associated with Influenza vaccine(split virion,BK-01 adjuvant)
Login to view more data
100 Translational Medicine associated with Influenza vaccine(split virion,BK-01 adjuvant)
Login to view more data
100 Patents (Medical) associated with Influenza vaccine(split virion,BK-01 adjuvant)
Login to view more data
100 Deals associated with Influenza vaccine(split virion,BK-01 adjuvant)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanPhase 3
China
Changchun BCHT Biotechnology Co.Changchun BCHT Biotechnology Co.
01 Nov 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free